|Articles|June 8, 2020
Managing the COVID-19 Drug Safety Response
Author(s)MyMeds&Me
Current safety reporting systems cannot meet the demands of a COVID-19 response. Find out how digital transformation enables rapid understanding & management of drug safety.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Top Drugs at Risk of Supply Shortages: Report
2
How Compounding Has Become a Permanent Bridge for Healthcare Access: Q&A with Dr. Nicole Snow
3
Amazon One Medical Launches GLP-1 Management Program
4
Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast
5